Cargando…

Retraction: Icariin ameliorates palmitate-induced insulin resistance through reducing thioredoxin-interacting protein (TXNIP) and suppressing ER stress in C2C12 myotubes

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588688/
https://www.ncbi.nlm.nih.gov/pubmed/37869752
http://dx.doi.org/10.3389/fphar.2023.1299165
_version_ 1785123632406593536
collection PubMed
description
format Online
Article
Text
id pubmed-10588688
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105886882023-10-21 Retraction: Icariin ameliorates palmitate-induced insulin resistance through reducing thioredoxin-interacting protein (TXNIP) and suppressing ER stress in C2C12 myotubes Front Pharmacol Pharmacology Frontiers Media S.A. 2023-10-06 /pmc/articles/PMC10588688/ /pubmed/37869752 http://dx.doi.org/10.3389/fphar.2023.1299165 Text en Copyright © 2023 Frontiers Editorial Office. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Retraction: Icariin ameliorates palmitate-induced insulin resistance through reducing thioredoxin-interacting protein (TXNIP) and suppressing ER stress in C2C12 myotubes
title Retraction: Icariin ameliorates palmitate-induced insulin resistance through reducing thioredoxin-interacting protein (TXNIP) and suppressing ER stress in C2C12 myotubes
title_full Retraction: Icariin ameliorates palmitate-induced insulin resistance through reducing thioredoxin-interacting protein (TXNIP) and suppressing ER stress in C2C12 myotubes
title_fullStr Retraction: Icariin ameliorates palmitate-induced insulin resistance through reducing thioredoxin-interacting protein (TXNIP) and suppressing ER stress in C2C12 myotubes
title_full_unstemmed Retraction: Icariin ameliorates palmitate-induced insulin resistance through reducing thioredoxin-interacting protein (TXNIP) and suppressing ER stress in C2C12 myotubes
title_short Retraction: Icariin ameliorates palmitate-induced insulin resistance through reducing thioredoxin-interacting protein (TXNIP) and suppressing ER stress in C2C12 myotubes
title_sort retraction: icariin ameliorates palmitate-induced insulin resistance through reducing thioredoxin-interacting protein (txnip) and suppressing er stress in c2c12 myotubes
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588688/
https://www.ncbi.nlm.nih.gov/pubmed/37869752
http://dx.doi.org/10.3389/fphar.2023.1299165
work_keys_str_mv AT retractionicariinamelioratespalmitateinducedinsulinresistancethroughreducingthioredoxininteractingproteintxnipandsuppressingerstressinc2c12myotubes